Patients with dry eyes might complain of a big variety of symptoms, including blurred eyesight, ocular distress, tiring, soreness, pain, burning, photophobia, itch and a sand or gravel feeling. There is no single gold-standard test for the analysis of dry vision; the presence of dry eyes symptoms, ocular surface damage and tear film instability are used to diagnose this condition. A hierarchical approach based on disease severity is used in the management of dry eye. New agents such as topical cyclosporin represent a substantial advance in the administration of dry eye..Acetylon’s ective histone deacetylase inhibitors to end up being showcased at 54th ASH annual meeting Acetylon Pharmaceuticals Inc., a innovator in targeted epigenetic medication discovery and advancement for enhanced therapeutic outcomes, today announced that its selective histone deacetylase inhibitors will be featured in five posters and one oral display at the 54th Annual Interacting with of the American Culture of Hematology , december 8-11 taking place, 2012, in Atlanta, Georgia. These presentations will highlight three of Acetylon's development programs: ACY-1215, a selective HDAC6 inhibitor currently in two Phase 1b clinical trials for the treatment of relapsed or relapsed/refractory multiple myeloma, preclinical research of ACY-1215 for the treatment of lymphoma, and a selective HDAC1/2 inhibitor in preclinical studies for sickle cell beta-thalassemia and disease.